［26］HUANG C L，WANG Y M，LI X W，et features of patients infected with 2019 novel coronavirus in Wuhan，China［J］.Lancet，2020，395（）：：10.1016/S0140-6736（20）-5.

［27］XU X T，CHEN P，WANG J F，et of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission［J］.Sci China Life Sci，2020，63（3）：：10.1007/s-020-1637-5.

［28］MEHRA M R，RUSCHITZKA F，PATEL A or chloroquine with or without a macrolide for treatment of COVID-19：a multinational registry analysis［J］.Lancet，2020，395（）：1820.DOI：10.1016/S0140-6736（20）-6.

［29］MARIJON E，KARAM N，JOST D，et cardiac arrest during the COVID-19 pandemic in Paris，France：a population-based，observational study［J］.Lancet Public Health，2020：S2468-2667（20）-1.DOI：10.1016/S2468-2667（20）-1.

［30］KLOK F A，KRUIP M J H A，VAN DER MEER N J M，et of thrombotic complications in critically ill ICU patients with COVID-19［J］.Thromb Res，2020，191：：10.1016/

［31］WU Z Y，MCGOOGAN J of and important lessons from the coronavirus disease 2019 （COVID-19） outbreak in China：summary of a report of 72 314 cases from the Chinese center for disease control and prevention［J］.JAMA，2020.DOI：10.1001/

文章来源：《武汉冶金管理干部学院学报》 网址: http://www.whyjglgbxyxb.cn/qikandaodu/2021/0303/746.html